DOCSLIB.ORG

Hedonic Interruption of the Physiological Controls of Eating: Sites and Mechanisms

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Hedonic Interruption of the Physiological Controls of Eating: Sites and Mechanisms Dissertation der Graduate School of Systemic Neurosciences der Ludwig-Maximillians-Universität München Hedonic interruption of the physiological controls of eating: sites and mechanisms ESTE LEIDMAA PhD Thesis 5th of Febuary 2016 Thesis Advisory Committee Professor Osborne Almeida (Supervisor) Professor Christophe Magnan (2nd reviewer) Professor Heidrun Potschka Dr. Susanne E La Fleur (External reviewer) Prof. Harald Luksch (Reviewer from GSN) Date of the thesis defence: 22.06.2016 Pühendusega minu perele Table of Contents Table of Contents ........................................................................................................................... List of Abbreviations ...................................................................................................................... i Abstract ............................................................................................................................................ 5 Chapter 1. General Introduction ...................................................................................................... 7 1.1. Feeding – an essential behaviour .................................................................................... 8 1.1.1. Meeting the energy demands of brain and body ....................................................... 8 1.1.2. Overeating and obesity ............................................................................................. 10 1.1.3. Pathological consequences of obesity ...................................................................... 13 1.2. Endocrine regulation of food intake ............................................................................. 15 1.2.1. Hunger signals (ghrelin, distention, glucocorticoids) ............................................... 15 1.2.2. Energy and nutrient signals and sensing .................................................................. 17 1.2.3. Endocrine signals of satiety to the brain .................................................................. 21 1.3. From neural circuits and behavioural mechanisms to metabolic homeostasis ............ 29 1.3.1. Central reception and integration of peripheral signals........................................... 30 1.3.2. Sensory and behavioural circuits and mechanisms regulating food ingestion ........ 36 1.3.3 The apparent conflict between hedonic and homeostatic mechansims ................. 45 1.4. Aims of this thesis ......................................................................................................... 50 Chapter 2. Food Choice under Different Physiological States ........................................................ 51 Abstract ...................................................................................................................................... 52 2.1 Introduction ....................................................................................................................... 53 2.2 Materials and Methods ..................................................................................................... 53 2.3 Results ............................................................................................................................... 58 2.4. Discussion ...................................................................................................................... 66 Chapter 3. Mechanisms Responsible for Hedonic Overriding of Leptin Signals ............................ 71 Abstract ...................................................................................................................................... 72 3.1. Introduction .................................................................................................................. 73 3.2. Materials and Methods ................................................................................................. 74 3.3. Results ........................................................................................................................... 80 3.3.1. Identification of brain areas that may mediate hedonic eating ............................... 80 3.3.2. Leptin does not suppress palatable food (PF) intake ............................................... 84 3.4. Discussion ...................................................................................................................... 90 3.5. Supplementary observations ........................................................................................ 94 Chapter 4. Potential of Galanin to Restore Anorexigenic Effects of Leptin During Exposure to a Hedonic Food ............................................................................................................................... 101 Abstract .................................................................................................................................... 102 4.1 Introduction .................................................................................................................... 103 4.2 Materials and Methods ................................................................................................... 104 4.3 Results ............................................................................................................................. 106 4.4 Discussion ....................................................................................................................... 109 Chapter 5. General Discussion ..................................................................................................... 113 Acknowlegements .................................................................................................................... 127 Curriculum Vitae ...................................................................................................................... 129 Publications .............................................................................................................................. 133 Affidavit .................................................................................................................................... 135 List of author contributions ..................................................................................................... 137 References ................................................................................................................................... 139 LIST OF ABBREVIATIONS 2-way ANOVA Two factor analysis of variance 2-AG 2-arachidonoyl-sn-glycerol 3V Third (III) ventricle 5-HT 5-hydroxy-tryptamine, serotonin 5-HT2A 5-hydroxy-tryptamine receptor 2A α-MSH α -melanocyte-stimulating hormone Acetyl-CoA Acetyl coenzyme A ACTH Adrenal corticotropin releasing hormone AGEs Advanced glycosylated end products AgRP Agouti-related peptide AP Area postarema ARC Arcuate nucleus ATP Adenosine triphosphate BAT Brown adipose tissue BBB Blood-brain barrier BMI Body mass index BNST Bed nucleus of the stria terminalis BW Body weight CART Cocaine- and amphetamine-regulated transcript CB1 Cannabinoid receptor 1 CeA Central amygdala CCK Cholecystokinin CNVII Cranial nerve VII CNS Central nervous system CRH Corticotropin releasing hormone DA Dopamine DAB Diaminobenzidine DMH Dorsomedial hypothalamus DMNX Dorsal motor nucleus of the vagus DREADD Designer receptor exclusively activated by designer drugs ER Endoplasmic reticulum ERK1/2 Extracellular signal-regulated kinase-1 and -2 Exp 1 Experiment 1 i FAs Fatty acids FI Food intake FITC Fluorescein isothiocyanate FEOs Food-entrainable oscillators fMRI Functional magnetic resonance imaging FTO Fat mass and obesity-associated gene GABA Gamma-aminobutyric acid Gal Galanin Gal1R Galanin receptor 1 GCTA Genome-wide Complex Trait Analysis GHS-R Growth hormone secretagogue receptor GIP Glucose-dependent insulinotropic polypeptide GLP-1 Glucagon-like peptide 1 GLUT4 glucose transporter 4 GPCR G-protein coupled receptor GWAS Genome-wide association studies HDL High density lipoprotein HF High-fat HFD High-fat diet HPA axis Hypothalamic pituitary adrenal axis ICV Intra-cerebroventricular IHC Immunohistochemistry i.p. Intraperitoneal ISHH In situ hybridization histochemistry IRS Insulin receptor substrate proteins JAK2 Janus kinase-2 KO Knock-out LC Locus coeruleus LDL Low density lipoprotein LF Low-fat LepRb Long isoform of leptin receptor LH Lateral hypothalamus M Mean (average value) MC4R Melanocortin receptor 4 MCH Melanin-concentrating hormone ii MOR µ-opioid receptors mPFC Medial prefrontal cortex mRNA Messenger RNA MUFAs Monounsaturated fatty acids MZ Monozygotic NAc Nucleus accumbens NPY Neuropeptide Y NTS Nucleus of the solitary tract (Nucleus tractus solitarius) OECD Organization for Economic Cooperation & Development OEA Oleoylethanolamide OFC Orbitofrontal cortex OX Orexin OXM Oxyntomodulin OXY Oxytocin PBN Parabranchial nucleus PF Palatable food PI3k Phosphatidylinositol-3 kinase POMC Proopiomelanocortin PPARα Peroxisome proliferation activating receptor alpha PUFAs Polyunsaturated fatty acids PVN Paraventricular nucleus PYY Peptide tyrosine-tyrosine WHO World Health Organisation RNA Ribonucleic acid SC Standard chow SCN Suprachiasmatic nucleus SD Standard deviation of mean SEM Standard error of the mean SNPs Single nucleotide polymorphisms SOCS-3 Suppressor of cytokine signalling 3 STAT3 Signal transducer and activator of transcription 3 T2DM Type 2 diabetes mellitus TRH Thyrotropin releasing hormone TNFα Tumor necrosis factor alpha TZDs Thiazolidinediones iii VMH Ventromedial hypothalamus VLDL Very low density lipoprotein
Load more

Recommended publications
  • Hemodynamic and Renal Effects of Atrial Natriurectic Peptide in Normal
    European Journal of Clinical Investigation The Journal of the European Society for Clinical Investigation Editors-in-Chief R. Arnold, M. Brandis, M. Kern Editorial Board 0. L. M. Bijvoet, A. B. Boneu, G. B. Bolli, J. Brodehl, P. van Brummelen, U. Fölsch, E. Harms, R. D. Hesch, D. R. Higgs, K. Hierholzer, U. Keller, G. Klöppel, K. Kühn, S. Lamberts, H. Löffler, S. Matern, F. R. Matthias, K. H. Meyer z. Büschenfelde, S. Moncada, K. J. Netter, C. Nissen, G. Paumgartner, B. A. Peskar, L. B. A. van de Putte, M. J. Rennie, C. Reiger, E. O. Riecken, H. -D. Roher, H. H. Ropers, P. Schauder, G. Schernthaner, H. Scholz, K. Schrör, V. Schusdziarra, M. Sheppard, K. Sikora, M. V. Singer, E. Steiness, B. E. Strauer, K. Unsicker, G. Utermann, P. Verroust, P. v. Wiehert, R. Ziegler, R. Zinkernagel Volume 18,1988 Published for the European Society for Clinical Investigation by Blackwell Scientific Publications, Oxford London Edinburgh Boston Palo Alto Melbourne Published by Blackwell Scientific Publications Ltd, Osney Mead, Oxford OX2 OEL, U.K. © 1988 Blackwell Scientific Publications Ltd. Authorization of photocopy items for internal or personal use, or the internal or personal use of specific clients, is granted by Blackwell Scientific Publications Ltd for libraries and other users registered with the Copyright Clearance Center (CCC) Transactional Reporting Service, provided that the base fee of $3-00 per copy is paid directly to CCC, 27 Congress Street, Salem, MA 01970, U.S.A. Special requests should be addressed to the Editor. 0014-2972/88 $3 00. The use of registered names, trade marks, etc., in this publication does not imply, even in the absence of a specific statement, that such names are exempt from the relevant protective laws and regulation and therefore free for general use.
    [Show full text]
  • Discovery, Characterization, and Clinical Development of the Glucagon-Like Peptides
    Discovery, characterization, and clinical development of the glucagon-like peptides Daniel J. Drucker, … , Joel F. Habener, Jens Juul Holst J Clin Invest. 2017;127(12):4217-4227. https://doi.org/10.1172/JCI97233. Harrington Prize Essay Endocrinology Gastroenterology The discovery, characterization, and clinical development of glucagon-like-peptide-1 (GLP-1) spans more than 30 years and includes contributions from multiple investigators, science recognized by the 2017 Harrington Award Prize for Innovation in Medicine. Herein, we provide perspectives on the historical events and key experimental findings establishing the biology of GLP-1 as an insulin-stimulating glucoregulatory hormone. Important attributes of GLP-1 action and enteroendocrine science are reviewed, with emphasis on mechanistic advances and clinical proof-of-concept studies. The discovery that GLP-2 promotes mucosal growth in the intestine is described, and key findings from both preclinical studies and the GLP-2 clinical development program for short bowel syndrome (SBS) are reviewed. Finally, we summarize recent progress in GLP biology, highlighting emerging concepts and scientific insights with translational relevance. Find the latest version: https://jci.me/97233/pdf The Journal of Clinical Investigation HARRINGTON PRIZE ESSAY Discovery, characterization, and clinical development of the glucagon-like peptides Daniel J. Drucker,1 Joel F. Habener,2 and Jens Juul Holst3 1Lunenfeld-Tanenbaum Research Institute, Mt. Sinai Hospital, University of Toronto, Toronto, Ontario, Canada. 2Laboratory of Molecular Endocrinology, Massachusetts General Hospital, Harvard University, Boston, Massachusetts, USA. 3Novo Nordisk Foundation Center for Basic Metabolic Research, Department of Biomedical Sciences, University of Copenhagen, Copenhagen, Denmark. sequences of cloned recombinant cDNA copies of messenger RNAs.
    [Show full text]
  • Neural Mechanisms of Salt Avoidance in a Freshwater Fish
    Neural Mechanisms of Salt Avoidance in a Freshwater Fish The Harvard community has made this article openly available. Please share how this access benefits you. Your story matters Citation Herrera, Kristian J. 2019. Neural Mechanisms of Salt Avoidance in a Freshwater Fish. Doctoral dissertation, Harvard University, Graduate School of Arts & Sciences. Citable link http://nrs.harvard.edu/urn-3:HUL.InstRepos:42029741 Terms of Use This article was downloaded from Harvard University’s DASH repository, and is made available under the terms and conditions applicable to Other Posted Material, as set forth at http:// nrs.harvard.edu/urn-3:HUL.InstRepos:dash.current.terms-of- use#LAA Neural mechanisms of salt avoidance in a freshwater fish A dissertation presented by Kristian Joseph Herrera to The Department of Molecular and Cellular Biology in partial fulfillment of the requirements for the degree of Doctor of Philosophy in the subject of Biology Harvard University Cambridge, Massachusetts April 2019 © 2019 – Kristian Joseph Herrera All rights reserved. Dissertation advisor: Prof. Florian Engert Author: Kristian Joseph Herrera Neural mechanisms of salt avoidance in a freshwater fish Abstract Salts are crucial for life, and many animals will expend significant energy to ensure their proper internal balance. Two features necessary for this endeavor are the ability to sense salts in the external world, and neural circuits ready to execute appropriate behaviors. Most land animals encounter external salt through food, and, in turn, have taste systems that are sensitive to the salt content of ingested material. Fish, on the other hand, extract ions directly from their surrounding environment. As such, they have evolved physiologies that enable them to live in stable ionic equilibrium with their environment.
    [Show full text]
  • Taste and Smell Disorders in Clinical Neurology
    TASTE AND SMELL DISORDERS IN CLINICAL NEUROLOGY OUTLINE A. Anatomy and Physiology of the Taste and Smell System B. Quantifying Chemosensory Disturbances C. Common Neurological and Medical Disorders causing Primary Smell Impairment with Secondary Loss of Food Flavors a. Post Traumatic Anosmia b. Medications (prescribed & over the counter) c. Alcohol Abuse d. Neurodegenerative Disorders e. Multiple Sclerosis f. Migraine g. Chronic Medical Disorders (liver and kidney disease, thyroid deficiency, Diabetes). D. Common Neurological and Medical Disorders Causing a Primary Taste disorder with usually Normal Olfactory Function. a. Medications (prescribed and over the counter), b. Toxins (smoking and Radiation Treatments) c. Chronic medical Disorders ( Liver and Kidney Disease, Hypothyroidism, GERD, Diabetes,) d. Neurological Disorders( Bell’s Palsy, Stroke, MS,) e. Intubation during an emergency or for general anesthesia. E. Abnormal Smells and Tastes (Dysosmia and Dysgeusia): Diagnosis and Treatment F. Morbidity of Smell and Taste Impairment. G. Treatment of Smell and Taste Impairment (Education, Counseling ,Changes in Food Preparation) H. Role of Smell Testing in the Diagnosis of Neurodegenerative Disorders 1 BACKGROUND Disorders of taste and smell play a very important role in many neurological conditions such as; head trauma, facial and trigeminal nerve impairment, and many neurodegenerative disorders such as Alzheimer’s, Parkinson Disorders, Lewy Body Disease and Frontal Temporal Dementia. Impaired smell and taste impairs quality of life such as loss of food enjoyment, weight loss or weight gain, decreased appetite and safety concerns such as inability to smell smoke, gas, spoiled food and one’s body odor. Dysosmia and Dysgeusia are very unpleasant disorders that often accompany smell and taste impairments.
    [Show full text]
  • Chapter 16 Lecture Outline A. Gustation
    Anatomy Lecture Notes Chapter 16 Chapter 16 Lecture Outline A. gustation - gustatory receptor cells are located in organs called taste buds 1. taste buds located in mucosa of mouth and pharynx most are on the sides of fungiform and circumvallate papillae 2. taste buds made of epithelial cells taste pores are openings in the surface of the epithelium gustatory cells - receptor cells supporting cells - separate gustatory cells from each other basal cells - immature cells that replace the other cells 3. gustatory cells have microvilli on apical surface, just inside taste pore membrane covering microvilli contains receptors for sweet, salty, sour, bitter and umami (glutamate) gustatory cells synapse with sensory neurons at base of taste bud Strong/Fall 2008 page 1 Anatomy Lecture Notes Chapter 16 4. gustatory cells activated when molecules dissolved in saliva bind to membrane receptors on microvilli gustatory cell releases neurotransmitter, which initiates action potential in sensory neuron 5. afferent pathways: VII - facial anterior 2/3 of tongue IX - glossopharyngeal posterior 1/3 of tongue X - vagus epiglottis and pharynx sensory neurons terminate in solitary nucleus in medulla oblongata thalamus gustatory cortex B. olfaction - receptors located in olfactory epithelium 1. olfactory epithelium covers superior nasal conchae and superior nasal septum 2. olfactory epithelium contains olfactory cells bipolar neuron receptors supporting cells columnar e. basal cells form new olfactory cells 3. olfactory cells have apical dendrites that project
    [Show full text]
  • 1 to the Stomach Inhibits Gut-Brain Signalling by the Satiety Hormone Cholecystokinin (CCK)
    Targeted Expression of Plasminogen Activator Inhibitor (PAI)-1 to the Stomach Inhibits Gut-Brain Signalling by the Satiety Hormone Cholecystokinin (CCK) Thesis submitted in accordance with the requirements of the University of Liverpool for the degree of Doctor in Philosophy By Joanne Gamble October 2013 I For Lily, you are the sunshine in my life…. II Table of Contents Figures and tables VII Acknowledgements XI Publications XIII Abstract XIV Chapter 1 ................................................................................................................................ 1 1.1 Overview ........................................................................................................................... 2 1.2 The Gastrointestinal Tract and Digestive Function ...................................................... 4 1.2.1 Distribution, Structure and Biology of Enteroendocrine (EEC) Cells ........................ 5 1.2.2 Luminal Sensing ......................................................................................................... 6 1.3 Energy Homeostasis ......................................................................................................... 7 1.3.1 Gut Hormones ........................................................................................................... 10 1.3.1.1 The Gastrin Family ............................................................................................ 11 1.3.2 PP-fold Family .........................................................................................................
    [Show full text]
  • Defects in Α-Cell Function in Patients with Diabetes Due to Chronic
    Diabetes Care 1 Lena Mumme,1 Thomas G.K. Breuer,1 Defects in -Cell Function in CLIN CARE/EDUCATION/NUTRITION/PSYCHOSOCIAL a Stephan Rohrer,1 Nina Schenker,1 Patients With Diabetes Due to Bjorn¨ A. Menge,1 Jens J. Holst,2 Michael A. Nauck,1 and Juris J. Meier1 Chronic Pancreatitis Compared With Patients With Type 2 Diabetes and Healthy Individuals https://doi.org/10.2337/dc17-0792 OBJECTIVE Diabetes frequently develops in patients with chronic pancreatitis. We examined the alterations in the glucagon response to hypoglycemia and to oral glucose adminis- tration in patients with diabetes due to chronic pancreatitis. RESEARCH DESIGN AND METHODS Ten patients with diabetes secondary to chronic pancreatitis were compared with 13 patients with type 2 diabetes and 10 healthy control subjects. A stepwise hypo- glycemic clamp and an oral glucose tolerance test (OGTT) were performed. RESULTS Glucose levels during the OGTT were higher in patients with diabetes and chronic pancreatitis and lower in control subjects (P < 0.0001). Insulin and C-peptide levels were reduced, and the glucose-induced suppression of glucagon was impaired in both groups with diabetes (all P < 0.0001 vs. control subjects). During hypoglycemia, glucagon concentrations were reduced in patients with chronic pancreatitis and with type 2 diabetes (P < 0.05). The increase in glucagon during the clamp was inversely related to the glucose-induced glucagon suppression and positively related to b-cell function. Growth hormone responses to hypoglycemia were lower in patients with type 2 diabetes (P = 0.0002) but not in patients with chronic pancreatitis. 1Diabetes Division, Department of Medicine I, CONCLUSIONS St.
    [Show full text]
  • Trkb Expression and Dependence Divides Gustatory Neurons Into Three Subpopulations Jennifer Rios-Pilier and Robin F
    Rios-Pilier and Krimm Neural Development (2019) 14:3 https://doi.org/10.1186/s13064-019-0127-z RESEARCHARTICLE Open Access TrkB expression and dependence divides gustatory neurons into three subpopulations Jennifer Rios-Pilier and Robin F. Krimm* Abstract Background: During development, gustatory (taste) neurons likely undergo numerous changes in morphology and expression prior to differentiation into maturity, but little is known this process or the factors that regulate it. Neuron differentiation is likely regulated by a combination of transcription and growth factors. Embryonically, most geniculate neuron development is regulated by the growth factor brain derived neurotrophic factor (BDNF). Postnatally, however, BDNF expression becomes restricted to subpopulations of taste receptor cells with specific functions. We hypothesized that during development, the receptor for BDNF, tropomyosin kinase B receptor (TrkB), may also become developmentally restricted to a subset of taste neurons and could be one factor that is differentially expressed across taste neuron subsets. Methods: We used transgenic mouse models to label both geniculate neurons innervating the oral cavity (Phox2b+), which are primarily taste, from those projecting to the outer ear (auricular neurons) to label TrkB expressing neurons (TrkBGFP). We also compared neuron number, taste bud number, and taste receptor cell types in wild-type animals and conditional TrkB knockouts. Results: Between E15.5-E17.5, TrkB receptor expression becomes restricted to half of the Phox2b + neurons. This TrkB downregulation was specific to oral cavity projecting neurons, since TrkB expression remained constant throughout development in the auricular geniculate neurons (Phox2b-). Conditional TrkB removal from oral sensory neurons (Phox2b+) reduced this population to 92% of control levels, indicating that only 8% of these neurons do not depend on TrkB for survival during development.
    [Show full text]
  • Important Interaction Between Urethral Taste Bud-Like Structures and Onuf's
    +Model ANDROL-280; No. of Pages 10 ARTICLE IN PRESS Revista Internacional de Andrología xxx (xxxx) xxx---xxx www.elsevier.es/andrologia ORIGINAL Important interaction between urethral taste bud-like structures and Onuf’s nucleus following spinal subarachnoid hemorrhage: A hypothesis for the mechanism of dysorgasmia a b,∗ c d Ozgur Caglar , Mehmet Dumlu Aydin , Nazan Aydin , Ali Ahiskalioglu , e f g Ayhan Kanat , Remzi Aslan , Arif Onder a Department of Pediatric Surgery, Medical Faculty of Ataturk University, Erzurum, Turkey b Department of Neurosurgery, Medical Faculty of Ataturk University, Erzurum, Turkey c Department of Psychology, Humanities and Social Sciences Faculty, Uskudar University, Istanbul, Turkey d Department of Anesthesiology, Medical Faculty of Ataturk University, Erzurum, Turkey e Department of Neurosurgery, Medical Faculty of RTE University, Rize, Turkey f Department of Pathology, Medical Faculty of Ataturk University, Erzurum, Turkey g Department of Neurosurgery, Medical Faculty of Inonu University, Malatya, Turkey Received 30 October 2019; accepted 26 May 2020 KEYWORDS Abstract Urethral taste buds; Background: We previously postulated that orgasmic sensation may occur through recently Subarachnoid discovered genital taste bud-like structures. The interaction between the pudendal nerve haemorrhage; and Onuf’s nucleus may be important for developing orgasmic information. The study aims Anorgasmia to investigate whether ischemic damage to Onuf’s nucleus-pudendal network following spinal subarachnoid hemorrhage (SAH) causes taste bud degeneration or not. Methods: The study was conducted on 22 fertile male rabbits who were divided into three 3 groups: control (GI; n = 5), SHAM (GII; n = 5) and study (GIII; n = 12). Isotonic solution, .7 cm , 3 for the SHAM, and .7 cm homologous blood was injected into spinal subarachnoid spaces at S2 level of the study group.
    [Show full text]
  • Hormonal Control of Glucose Homoeostasis in Ruminants
    PYOC.Nutr. SOC.(1983), 42, 149 '49 Hormonal control of glucose homoeostasis in ruminants By G. H. MCDOWELL,Dairy Research Unit, Department of Animal Husbandry, University of Syndey, Camden, NSW, 2570, Australia Little, if any, glucose is absorbed from the alimentary tract of the grazing ruminant and it appears that significant absorption of glucose only occurs in ruminants consuming relatively large amounts of grain (Bergman, 1973; Lindsay, 1978). In spite of this, ruminants have an absolute requirement for glucose which is similar to that of nonruminants. Certainly glucose is an essential metabolite for the brain as there is no oxidation of ketones in the brain of the ruminant (Lindsay, 1980). Moreover, glucose is required for turnover and synthesis of fat, as a precursor of muscle glycogen and in pregnant and lactating ruminants, glucose is an essential metabolite. Indeed the glucose requirements of late-pregnant and lactating ruminants increase dramatically beyond that required for maintenance (Bergman, 1973, see also Table 2, p. 164). It is not surprising that volatile fatty acids derived from rumen fermentation of carbohydrate provide some 70% of the energy requirements of the ruminant (Bergman, 1973). Even so, gluconeogenesis and the maintenance of glucose homoeostasis are critical processes in view of the absolute requirements for glucose. Unlike the situation in monogastric species, gluconeogenesis is maximal after feed ingestion and decreases during food restriction. The major factor influencing the rate of gluconeogenesis is the availability of substrates (Lindsay, 1978). In fed ruminants the principal precursors are propionate and amino acids, with lactate and glycerol making minor contributions to glucose production.
    [Show full text]
  • Gut Hormones
    259 PROCEEDINGS OF THE NUTRITION SOCIETY The Three Hundred and Eighteenth Scktajk Meeting was held in the Medical and Biological Sciences Building, University of Southampton, on 20 and 21 July I978 SYMPOSIUM ON ‘HORMONES AND FOOD UTILIZATION’ Gut hormones By S. R. BLOOM, Department of Medicine and J. M. POLAK,Department of Pathology, The Royal Postgraduate Medical School, Hamwsmith Hospital, Du Cane Road, London W12 oHS History At the end of the last century Pavlov proposed that the control of alimentary function was by nervous reflex. His explanation was intellectually satisfying and a great advance on previous extremely woolly theories. Histologically fine nerve fibres which could be seen running in the gut w& and sectioning the main nerve trunks undoubtedly affected gastrointestinal function. Meanwhile, however, Brown Sequard, attempting to rejuvenate his ageing body, was able to show that extracts of testes greatly increased his prowess in several directions. His findings, published in 1889, caught the public imagination and by the end of the century extracts of numerous organs were available for the purpose of treating real and imagined ailments. Thus when Bayliss & Starling were investigating the influence of the duodenum on the exocrine pancreas, the idea of making duodenal extracts came readily. They were astonished to find that such an extract had all the effects on the exocrine pancreas that had been previously attributed to Pavlov’s nervous reflexes. They proposed that there must be a chemical messenger released from the duodenum which acted via the circulation and proposed the term hormone. Nature of the gut endocrine system Although the first substance to be named hormone, secretin, was from the alimentary tract, progress in the understanding of gut endocrinology was very slow.
    [Show full text]
  • Nomina Histologica Veterinaria, First Edition
    NOMINA HISTOLOGICA VETERINARIA Submitted by the International Committee on Veterinary Histological Nomenclature (ICVHN) to the World Association of Veterinary Anatomists Published on the website of the World Association of Veterinary Anatomists www.wava-amav.org 2017 CONTENTS Introduction i Principles of term construction in N.H.V. iii Cytologia – Cytology 1 Textus epithelialis – Epithelial tissue 10 Textus connectivus – Connective tissue 13 Sanguis et Lympha – Blood and Lymph 17 Textus muscularis – Muscle tissue 19 Textus nervosus – Nerve tissue 20 Splanchnologia – Viscera 23 Systema digestorium – Digestive system 24 Systema respiratorium – Respiratory system 32 Systema urinarium – Urinary system 35 Organa genitalia masculina – Male genital system 38 Organa genitalia feminina – Female genital system 42 Systema endocrinum – Endocrine system 45 Systema cardiovasculare et lymphaticum [Angiologia] – Cardiovascular and lymphatic system 47 Systema nervosum – Nervous system 52 Receptores sensorii et Organa sensuum – Sensory receptors and Sense organs 58 Integumentum – Integument 64 INTRODUCTION The preparations leading to the publication of the present first edition of the Nomina Histologica Veterinaria has a long history spanning more than 50 years. Under the auspices of the World Association of Veterinary Anatomists (W.A.V.A.), the International Committee on Veterinary Anatomical Nomenclature (I.C.V.A.N.) appointed in Giessen, 1965, a Subcommittee on Histology and Embryology which started a working relation with the Subcommittee on Histology of the former International Anatomical Nomenclature Committee. In Mexico City, 1971, this Subcommittee presented a document entitled Nomina Histologica Veterinaria: A Working Draft as a basis for the continued work of the newly-appointed Subcommittee on Histological Nomenclature. This resulted in the editing of the Nomina Histologica Veterinaria: A Working Draft II (Toulouse, 1974), followed by preparations for publication of a Nomina Histologica Veterinaria.
    [Show full text]